false
Catalog
7561E Management of Opioid Use Disorder in the Hos ...
Q&A from 10-29
Q&A from 10-29
Back to course
Pdf Summary
The lecture on managing opioid use disorder in hospitalized adolescents addresses several key topics related to treatment and care protocols. The Clinical Opiate Withdrawal Scale (COWS) is a pivotal tool in evaluating withdrawal symptoms and guiding medication adjustments, such as buprenorphine dosages, which typically range between 16-24 mg for effectiveness. The COWS score is utilized alongside the patient's drug use history to prevent precipitated withdrawal. <br /><br />Patient safety requires 1:1 sitter coverage, especially for minors, due to the risks associated with withdrawal discomfort and potential flight. Visitation policies restrict access to primary caregivers only, to maintain a focused support environment. Limited phone access is granted, primarily through hospital landlines, to maintain contact with caregivers while minimizing external influences.<br /><br />Buprenorphine is available in various formulations, including injectable Sublocade for subcutaneous administration in the abdomen and sublingual versions, offering flexibility in treatment administration.<br /><br />Information dissemination to resident physicians is underway, with efforts to develop a pathway to guide care management. Additionally, resources and instructions tailored to inpatient settings are being considered for inclusion in discharge summaries, with coordination required from leadership and the EPIC team for implementation.<br /><br />Overall, the approach emphasizes comprehensive care, combining medical, safety, and communication strategies to support adolescents with opioid use disorder effectively during hospitalization.
Keywords
opioid use disorder
hospitalized adolescents
Clinical Opiate Withdrawal Scale
COWS score
buprenorphine dosages
patient safety
Sublocade
care management
discharge summaries
EPIC team
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English